KNSA Historical PE Ratio image   This KNSA PE ratio history page last updated 8/5/2022
KNSA Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/3/2022
10.68-0.29-1.16NA
Q1 2022
5/3/2022
10.11-0.36-1.44NA
Q4 2021
2/22/2022
10.62-0.53-2.12NA
Q3 2021
11/1/2021
12.73-0.44-1.76NA
Q2 2021
8/3/2021
13.69-0.61-2.44NA
Q1 2021
5/4/2021
15.78-0.72-2.88NA
Q4 2020
2/23/2021
21.84-0.79-3.16NA
Q3 2020
11/5/2020
16.22-0.66-2.64NA
Q2 2020
7/30/2020
19.62-0.65-2.60NA
Q1 2020
4/28/2020
20.83-0.48-1.92NA
Q4 2019
2/26/2020
18.23-0.58-2.32NA
Q3 2019
10/28/2019
6.20-0.49-1.96NA
Q2 2019
8/12/2019
10.99-0.68-2.72NA
Q1 2019
5/2/2019
14.59-1.27-5.08NA
Q4 2018
3/7/2019
16.18-0.88-3.52NA
Q3 2018
11/1/2018
20.13-0.51-2.04NA
Q2 2018
8/6/2018
13.88-0.97-3.88NA
KNSA PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/3/2022
10.68-0.29-1.62NA
Q1 2022
5/3/2022
10.11-0.36-1.94NA
Q4 2021
2/22/2022
10.62-0.53-2.30NA
Q3 2021
11/1/2021
12.73-0.44-2.56NA
Q2 2021
8/3/2021
13.69-0.61-2.78NA
Q1 2021
5/4/2021
15.78-0.72-2.82NA
Q4 2020
2/23/2021
21.84-0.79-2.58NA
Q3 2020
11/5/2020
16.22-0.66-2.37NA
Q2 2020
7/30/2020
19.62-0.65-2.20NA
Q1 2020
4/28/2020
20.83-0.48-2.23NA
Q4 2019
2/26/2020
18.23-0.58-3.02NA
Q3 2019
10/28/2019
6.20-0.49-3.32NA
Q2 2019
8/12/2019
10.99-0.68-3.34NA
Q1 2019
5/2/2019
14.59-1.27-3.63NA
Q4 2018
3/7/2019
16.18-0.88NANA
Q3 2018
11/1/2018
20.13-0.51NANA
Q2 2018
8/6/2018
13.88-0.97NANA
Quotes delayed 20 minutes

Email EnvelopeFree KNSA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Kiniksa Pharmaceuticals (KNSA) is categorized under the Miscellaneous sector; to help you further research PE history across stocks, below are some other companies in the same sector:

KPLT PE Ratio History
LAZR PE Ratio History
LFG PE Ratio History
LIDR PE Ratio History
LILA PE Ratio History
LILM PE Ratio History
LIVN PE Ratio History
LOCL PE Ratio History
LPG PE Ratio History
LTCH PE Ratio History
How should the KNSA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Kiniksa Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this KNSA Historical PE Ratio page.

What is the average historical PE for KNSA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The KNSA historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for KNSA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The KNSA historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the KNSA Historical PE Ratio information for Kiniksa Pharmaceuticals' stock. The average KNSA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average KNSA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this KNSA historical PE result, against the recent PE: when this page was posted on 8/4/2022, the most recent closing price for KNSA had been 11.69, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on KNSA or any other given stock, valuation analysis for KNSA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Kiniksa Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for KNSA. Thanks for visiting, and the next time you need to research KNSA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: EWL Historical Stock Prices, Top Ten Hedge Funds Holding BBIG, VOT YTD Return.

 

KNSA Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.